Lv21
110 积分 2025-11-14 加入
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
10小时前
待确认
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
2个月前
已完结
Systematic profiling of tumor-associated antigen expression for antibody-drug conjugate in prostate cancer
3个月前
已完结
Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians
3个月前
已完结
Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis
3个月前
已完结
Kinetics and metabolism of intramuscular neostigmine in myasthenia gravis
4个月前
已完结
Postoperative Urinary Retention
4个月前
已完结
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study
4个月前
已完结
Cabozantinib plus atezolizumab in metastatic prostate cancer (CONTACT-02): final analyses from a phase 3, open-label, randomised trial
5个月前
已完结
皖公网安备34019202002308
